Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014610 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Enoxacin |
---|
Description | Enoxacin, also known as ENX or penetrex, belongs to the class of organic compounds known as naphthyridine carboxylic acids and derivatives. Naphthyridine carboxylic acids and derivatives are compounds containing a naphthyridine moiety, where one of the ring atoms bears a carboxylic acid group. Enoxacin is a drug which is used for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to escherichia coli, staphylococcus epidermidis, or staphylococcus saprophyticus, and (3) complicated urinary tract infections due to escherichia coli, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa, staphylococcus epidermidis, or enterobacter cloacae. Enoxacin is a very strong basic compound (based on its pKa). |
---|
Structure | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1 InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23) |
---|
Synonyms | Value | Source |
---|
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid | ChEBI | 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid | ChEBI | Enoxacine | ChEBI | Enoxacino | ChEBI | Enoxacinum | ChEBI | ENX | Kegg | Penetrex | Kegg | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylate | Generator | 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylate | Generator | Enoxin | HMDB | Rhône poulenc rorer brand OF enoxacin sesquihydrate | HMDB | Enoxor | HMDB | Enoxacin sesquihydrate | HMDB | Faulding brand OF enoxacin | HMDB | Pierre fabre brand OF enoxacin sesquihydrate | HMDB | Rhône-poulenc rorer brand OF enoxacin sesquihydrate | HMDB | Sesquihydrate, enoxacin | HMDB |
|
---|
Chemical Formula | C15H17FN4O3 |
---|
Average Molecular Weight | 320.3189 |
---|
Monoisotopic Molecular Weight | 320.128468635 |
---|
IUPAC Name | 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
---|
Traditional Name | enoxacin |
---|
CAS Registry Number | 74011-58-8 |
---|
SMILES | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1 |
---|
InChI Identifier | InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23) |
---|
InChI Key | IDYZIJYBMGIQMJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as naphthyridine carboxylic acids and derivatives. Naphthyridine carboxylic acids and derivatives are compounds containing a naphthyridine moiety, where one of the ring atoms bears a carboxylic acid group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Naphthyridines |
---|
Direct Parent | Naphthyridine carboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Naphthyridine carboxylic acid
- Fluoroquinolone
- N-arylpiperazine
- Pyridinylpiperazine
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Dialkylarylamine
- Aminopyridine
- Aryl fluoride
- Aryl halide
- 1,4-diazinane
- Piperazine
- Imidolactam
- Pyridine
- Heteroaromatic compound
- Vinylogous amide
- Amino acid or derivatives
- Amino acid
- Azacycle
- Secondary amine
- Carboxylic acid derivative
- Carboxylic acid
- Secondary aliphatic amine
- Monocarboxylic acid or derivatives
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 220 - 224 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.09 g/L | Not Available | LogP | 2.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Enoxacin,1TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCNCC3)N=C21 | 2783.3 | Semi standard non polar | 33892256 | Enoxacin,1TMS,isomer #2 | CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)N=C21 | 3021.5 | Semi standard non polar | 33892256 | Enoxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)N=C21 | 2909.9 | Semi standard non polar | 33892256 | Enoxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)N=C21 | 2874.3 | Standard non polar | 33892256 | Enoxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)N=C21 | 3660.4 | Standard polar | 33892256 | Enoxacin,1TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCNCC3)N=C21 | 2978.6 | Semi standard non polar | 33892256 | Enoxacin,1TBDMS,isomer #2 | CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)N=C21 | 3227.8 | Semi standard non polar | 33892256 | Enoxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)N=C21 | 3292.2 | Semi standard non polar | 33892256 | Enoxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)N=C21 | 3281.7 | Standard non polar | 33892256 | Enoxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)N=C21 | 3798.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Enoxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zi0-1093000000-241451e66e16daabab83 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Enoxacin GC-MS (1 TMS) - 70eV, Positive | splash10-00b9-2039000000-3aaed983f26fc10675b9 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Enoxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-qTof , Positive-QTOF | splash10-0pc0-2691000000-70495182f5d53b3e2f3e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-00di-0009000000-c343d2455564f9c283ab | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-00di-0039000000-c8fb064ca8dcd22fd051 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-00di-0069000000-6f1cc68c72c995af1700 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-05fr-0195000000-f089fb10889524908bb9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-0udi-0391000000-342a8fc923e2f74b2c2f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin LC-ESI-QFT , positive-QTOF | splash10-0udi-0970000000-ad4c54479d1e64d34d71 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin , positive-QTOF | splash10-0pc0-2691000000-70495182f5d53b3e2f3e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 90V, Positive-QTOF | splash10-0udi-0970000000-bb0d7bb58daaabaa5d30 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 60V, Positive-QTOF | splash10-05fr-0095000000-e5aecf8dae20a8173ba7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 75V, Positive-QTOF | splash10-0udi-0391000000-9c0a1a78d2583bd88339 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 45V, Positive-QTOF | splash10-00di-0069000000-0e21ce47b095471d4c88 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 30V, Positive-QTOF | splash10-00di-0039000000-56c5deec0bec46a6ccc6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoxacin 15V, Positive-QTOF | splash10-00di-0009000000-be580c5bfc772c508991 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 10V, Positive-QTOF | splash10-00di-0029000000-b768a8766a208143ef4d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 20V, Positive-QTOF | splash10-0fi9-3095000000-4d791244c2706826943a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 40V, Positive-QTOF | splash10-002f-3090000000-449abf1ea9e4d691dee5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 10V, Negative-QTOF | splash10-00or-0094000000-2dfdf64dcd801c343137 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 20V, Negative-QTOF | splash10-002b-0190000000-6184732185fc1f37ecef | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 40V, Negative-QTOF | splash10-000e-6490000000-d025aca1fd56c040e757 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 10V, Positive-QTOF | splash10-00di-0009000000-a42c0b05ac20f28b16b2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 20V, Positive-QTOF | splash10-0udi-0029000000-7012f2139eff8aba307f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 40V, Positive-QTOF | splash10-0059-0091000000-8e32867f3fee05370a41 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 10V, Negative-QTOF | splash10-0axs-0092000000-89be0bf06b51a26e9b3d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoxacin 20V, Negative-QTOF | splash10-0002-0090000000-bbe88efb18ff81eade78 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|